This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Dongwha Pharm. Ind. Co., Ltd.. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kyunggi-do, KR (2003)
- Anyarg-si, KR (2004)
Company Filing History:
Years Active: 2003-2004
Title: A Closer Look at Inventor Jin Soo Lee
Introduction
Jin Soo Lee is a notable inventor based in Anyang-si, South Korea, with a strong focus on developing innovative compounds in the field of pharmaceuticals. He holds two patents that contribute significantly to antibacterial agents and their efficacy.
Latest Patents
Jin Soo Lee's latest patents include groundbreaking work on optically active quinoline carboxylic acid derivatives featuring 7-pyrrolidine substituents that generate optical activity. The inventions detail processes for the synthesis of these derivatives, which include pharmaceutically acceptable salts and solvates. Notably, these compounds demonstrate superior antibacterial activity and enhanced pharmacokinetic profiles compared to their enantiomers and conventional agents, while exhibiting negligible phototoxicity. This makes the compounds highly valuable for use as antibacterial agents.
Career Highlights
Currently, Jin Soo Lee is affiliated with Dongwha Pharmaceutical Industries Co., Ltd., a company renowned for its commitment to healthcare and drug development. His work here focuses on advancing pharmaceutical research and developing innovative solutions for medical challenges.
Collaborations
Throughout his career, Jin Soo Lee has collaborated with esteemed colleagues, including Sung June Yoon and Yong Ho Chung. These partnerships have further enriched his research endeavors and contributed to the development of effective pharmaceutical products.
Conclusion
In summary, Jin Soo Lee stands out as a remarkable inventor in the pharmaceutical industry. His contributions to developing optically active quinoline carboxylic acid derivatives significantly enhance the potential for new antibacterial treatments. With ongoing collaborations and work at Dongwha Pharmaceutical Industries Co., Ltd., he remains an influential figure in the realm of innovation and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile